J Rhinol.  2016 May;23(1):39-43. 10.18787/jr.2016.23.1.39.

Analysis of Characteristics and Steroid Effects in Olfactory Dysfunction Patients

Affiliations
  • 1Department of Otolaryngology Head and Neck Surgery, Gachon University, Incheon, Korea. atmaasiris@gmail.com

Abstract

BACKGROUND AND OBJECTIVES
Olfactory dysfunction is a common sensory disorder, but there are currently no standard diagnostics or therapeutic methods. We analyzed the effects of systemic steroid therapy in patients with olfactory dysfunction. MATERIALS AND METHOD: We analyzed patients who visited our ENT department with olfactory dysfunction for 3 years. We reviewed their charts and classified the patients according to age, sex, etiology of olfactory dysfunction, degrees of olfactory dysfunction and the effect of systemic steroid therapy.
RESULTS
The mean age was 44.3 years old and there were 50 males and 55 females; 55 patients had inflammatory disease and 50 patients had non-inflammatory disease. The distribution of degrees of olfactory disorder according to cause was not significantly different (p=0.120). In 105 patients, 20% experienced improvements after systemic steroid therapy, and the response of systemic steroid therapy was better among patients with inflammatory causes. In cases of inflammatory disease, there was a larger amount of severe hyposmia patients, and their response to systemic steroid therapy was significant (p=0.015). Patients with mild and moderate hyposmia were more responsive to systemic steroid therapy than patients with severe hyposmia (p=0.382).
CONCLUSION
In cases of hyposmia due to inflammatory disease, systemic steroid therapy with proper operative management may increase therapeutic effects.

Keyword

Hyposmia; Steroid

MeSH Terms

Female
Humans
Male
Methods
Sensation Disorders
Therapeutic Uses
Therapeutic Uses

Cited by  3 articles

The Predictive Factors of Olfactory Changes after Endoscopic Sinus Surgery
Mi Kyung Ye
J Rhinol. 2018;25(2):63-68.    doi: 10.18787/jr.2018.25.2.63.

Comparing the Effectiveness of Olfactory Training, According as Type and Preference of Odorant
Dong Young Kim, Jung Ho Ha, Ju Ho Lee, Hyun Jun Kim, Do-Yang Park
J Rhinol. 2019;26(2):92-98.    doi: 10.18787/jr.2019.26.2.92.

Clinical Feasibility of Scent Survey for Screening Test for Olfactory Function
Youngsoo Yang, Hye Rang Choi, Jae Hoon Cho, Seok-Chan Hong, Jin Kook Kim
J Rhinol. 2018;25(1):14-20.    doi: 10.18787/jr.2018.25.1.14.


Reference

References

1). Min YG, Lee CH, Kwon TY, Lee CH, Yun JB, Lee KS. Quantitative Evaluation of Systemic Steroid Therapy for the Patients with Olfactory Dysfunction. Korean J Otolaryngol. 1998; 41(1):37–41.
2). Hong SC, Yoo YS, Kim SC, Kim YC, Kim YS. Transition of the Olfactory Recovery in Patients with Olfactory Disturbance. Korean J Otolaryngol. 2000; 43:844–8.
3). Takagi SF. Standardized olfactometries in Japan-a review over ten years. Chem Senses. 1989; 14:25–46.
Article
4). Dhong HJ, Shin DB, Rho HI, Chung SK, Chu KC. Clinical Analysis of Olfactory Disorders. Korean J Otolaryngol. 2001; 44:946–50.
5). Sccoott AE. Clinical characteristic of taste and smell disorders. Ear Nose Throat J. 1989; 68:297–315.
6). Jafek BW, Moran DT, Eller PM, Carter JR, Jafek TB. Steroid-dependent anosmia. Arch Otolaryngol Head Neck Surg. 1987; 113:547–9.
Article
7). Cain WS, Gent JF, Goodspeed RB, Leonard G, Haven N. Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope. 1998; 98:893–8.
Article
8). Duncan HJ, Seiden AM. Long-term follow-up of olfactory loss secondary to head trauma and upper respiratory tract infection. Arch Otolaryngol Head Neck Surg. 1995; 121:1183–7.
Article
9). Schriever VA, Merkonidis C, Gupta N, Hummel C, Hummel T. Treatment of smell loss with systemic methylprednisolone. Rhinology. 2012; 50:284–9.
Article
10). Davison Tm, Murphy C, Jalowayski AA. Smell impairment: Can it be reversed? Postfrad Med. 1995; 98:107–18.
11). Cain WS. Testing olfaction in a clinical setting. Ear Nose Throat J. 1989; 68:316–28.
12). Rachel KH, Matthew CL. Exogenous Cushing's Syndrome and Glucocorticoid Withdrawal. Endocrinology and Metabolism Clinics of North America. 2005; 34:371–84.
Article
13). Park YJ. Functional Activity of the Central Olfactory Pathways. J Rhinol. 2006; 13(1):10–17.
14). Park HJ, Lee SS, Byun SW, Bae JH. Alteration of Olfactory Function in Chronic Viral Hepatitis Patients. J Rhinol. 2009; 16(2):95–8.
15). Wolfenberger M, Hummel T. Anti-inflammatory and Surgical Therapy of Olfactory Disorder Related to Sinonasal Disease. Chemical Senses. 2002; 27:617–22.
16). Min Y, Son BH, Lee KS, Yun JB, Shin JS, Yoo YS. Olfaction changes after endoscopic sinus surgery. Korean J Otolaryngol-Head Neck Surg. 1994; 37:710–7.
Full Text Links
  • JR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr